SCHEDULE OF WARRANTS ACTIVITY (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |
---|---|---|
Oct. 31, 2022 |
Oct. 31, 2021 |
|
Equity [Abstract] | ||
Warrants Outstanding, Beginning balance | 860,000 | 560,000 |
Weighted Average Exercise Price Per Share Warrants Outstanding, Ending balance | $ 5.36 | $ 4.71 |
Warrants Outstanding, Issued | 60,000 | 300,000 |
Weighted Average Exercise Price Per Share, Issued | $ 4.77 | $ 6.56 |
Warrants Outstanding, Exercised | (60,000) | |
Weighted Average Exercise Price Per Share, Exercised | $ 2.06 | |
Warrants Outstanding, Expired | (560,000) | |
Weighted Average Exercise Price Per Share, Expired | $ 4.71 | |
Warrants Outstanding and Exercisable, Shares | 300,000 | |
Warrants Outstanding and Exercisable, Per Share | $ 6.56 | |
Aggregate Intrinsic Value | $ 0 |
X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Warrants Exercisable. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share Warrants Outstanding, Beginning balance. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Issued. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price exercised. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price expired. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|